GYRE
Gyre Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.86
+6.52%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.31x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.24x
- Net debt / EBITDA
- 2.84x
Liquidity & coverage
- Current ratio
- 4.26x
- Quick ratio
- 3.86x
- Cash ratio
- 2.61x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $93.4M
Cash & dividend
- FCF / debt
- -4.91x
- Cash flow / debt
- -4.24x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- -83.2%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026